Navigation Links
Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research
Date:5/18/2009

fic, business and investment perspective on the potential of this area to become the next generation of biopharmaceutical drug targets.

"In these challenging times, Scotland's world-class talent, high-tech infrastructure and commitment to cross-sector collaboration provide a rich and innovative environment for life science investors," said Rhona Allison, Senior Director Life Sciences, Scottish Enterprise. "Major capital investments such as the new Edinburgh BioQuarter and the Scottish Centre for Regenerative Medicine -- led by Sir Ian Wilmut -- are only a few examples of how Scotland is helping companies quickly and effectively bring novel technologies and products to market."

Earlier this year, Scottish companies and organizations achieved stem cell breakthroughs in synthetic blood and embryonic and iPS (Induced pluripotent stem cells) technology and began stem cell clinical trials for corneal blindness and stroke, further reinforcing Scotland's world-leading position in the use of stem cell-based therapies. At BIO, government-sponsored innovation fund ITI Life Sciences and stem cell company Cellartis AB will offer insights into the company's new license to produce large volumes of high-quality, ethically-derived human embryonic stem cell lines (hES) and expand Scottish operations. NovaBiotics, one of Scotland's leading biotech companies focused on the design and development of antifungal and antibacterial therapeutics, will also be on hand to discuss the development of its lead product Novexatin(TM), a novel treatment for fungal nail infection.

    Scottish Organizations at BIO
    Accuro Biologics
    Aquapharm Biodiscovery Ltd
    AvantiCell Science Ltd
    BioFilm Limited
    BioOutsource
    Biotech Innovation and Future Health Limited
    Cellartis AB
    ClinTec International Ltd
    CXR Biosciences Ltd
    Devro Medical Limited
    Environmental Hygiene Products Ltd
    Equatec
    Fulcrum
'/>"/>
SOURCE Scottish Enterprise
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Scotland Showcased at BIO as Dynamic, Global Life Sciences Hub
2. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
3. Highlights of Economic and Business Growth in the Tampa Bay Region
4. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
5. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
6. Highlights of Economic and Business Growth in the Tampa Bay Region
7. Highlights of Economic and Business Growth in the Tampa Bay Region
8. Oncothyreon highlights corporate and clinical objectives for 2008
9. CyberKnife Users Meeting Highlights Major Clinical Data Milestones and Emerging Trends
10. National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights
11. MEDEA+ Noblanc award highlights improvements in microelectronics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...T, N.Y., Nov. 19 Dr. Mate Hidvegi,...responds to a press release issued on November 17 ...any for making false and self-serving statements a..., Dr. Hidvegi stated from his office in Budapest...rch on Avemar does not apply to AveULTRA, www.av...
(Date:11/19/2009)...MUNSTER, Germany, November 19 MONI...n November 16th, 2009 Flibanserin in the,indicatio...n Parkinson,s,disease for orphan drug status desig...Levodopa-induced dyskinesia is a complication of t...a serious burden to some of those,affected, since ...
(Date:11/19/2009)... VIENNA, Austria, November 19 AFFi...on one product candidate at an unexpectedly early,...s planned to enter into,Phase II clinical trial ea...ely follows the completion of two Phase I trials w...d its fast decision on the first interim,analysis ...
(Date:11/18/2009)...een,s University Belfast are developing new sensor...h will help in the fight against the threat of ter...el pads to ,swipe, an individual or crime scene to...ing instrument that can detect the presence of che...ter decisions to be made in response to terrorist ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2
...ces its focus on new Rapid-Fill ASF colored label ...cts at the 2008 American Society of Health-System ...on beginning today at the Orange County Convention... Dec. 8 Baxa Corporation is featuring its new Rap...y and Compliance Tools (PACT), Exacta-Mix Automate...
...Building on its flagship,suite of medication and i...y,launched the Pyxis(R) MedStation(R) 4000 and an ...provides hospitals with customized, actionable,rec... The Pyxis(R) MedStation(R) 4000 automated me...t can help hospitals increase the security of,high...
...ron alfa-2b) met its primary endpoint of non-infer...CHIEVE 2/3 trial in patients with genotypes 2 and ...ving 900-mcg Albuferon had comparable rates of ser...continuations due to adverse events, vs. peginterf...man Genome Sciences, Inc. (Nasdaq: HGSI ) today ...
Other Biology Technology:Baxa Features Rapid-Fill(TM) Colored Labels, PACT(TM) Products, Exacta-Mix(TM) 2400 Compounders and Abacus(TM) Software at the ASHP Mid-Year Clinical Meeting 2Baxa Features Rapid-Fill(TM) Colored Labels, PACT(TM) Products, Exacta-Mix(TM) 2400 Compounders and Abacus(TM) Software at the ASHP Mid-Year Clinical Meeting 3Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data 2Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data 3Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C 2Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C 3Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C 4Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C 5Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C 6Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C 7Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C 8Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C 9
(Date:11/22/2009)... A butterfly,s proboscis looks like a straw -- lon...ore like a paper towel, according to Konstantin Ko... tricks of this piece of insect anatomy to make sm...ls. , Kornev will present his work next week at ...ociety,s (APS) Division of Fluid Dynamics will tak...
(Date:11/20/2009)...ovember 2009 issue of the journal GENETICS ( htt...ly of genes (1-aminocyclopropane-1-carboxylate syn...n of ethylene. This gas affects many aspects of pl...ndation for future genetic manipulation that could...d thrive in difficult terrain, increase yields, an...
(Date:11/20/2009)...ntists from the Marine Biogeochemistry and Geology...oratory (NRL) organized and led a team of universi...on to initiate methane hydrate exploration in the ...f sediment contribution to Arctic climate change. ...a as a research platform, three cross-shelf transe...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2International expedition investigates climate change, alternative fuels in Arctic 2Switch program increases kids healthy eating reduces screen time 57952 1Switch program increases kids healthy eating reduces screen time 57952 2InfoLogix Selected by Albert Einstein Healthcare Network for eLearning Modules to Support EMR Implementation 57951 1InfoLogix Selected by Albert Einstein Healthcare Network for eLearning Modules to Support EMR Implementation 57951 2InfoLogix Selected by Albert Einstein Healthcare Network for eLearning Modules to Support EMR Implementation 57951 3Moroney 26 Gill Inc Launches New Website 57946 1
...ng calories leads to a longer life, scientists hav...rst time that such a diet also can maintain physic...y inevitable progression to physical disability an...odel of life-time caloric restriction, showed that...h expresses inflammatory factors that in humans ca...
...ern Reserve Universitys School of Medicine have pu...e discovery with a natural product derived from th... suggest a broad set of applications in various jo... osteoarthritis and irritable bowel syndrome., The...om a rainforest tree called Croton palanostigma, w...
...uate class, being given a dissertation by one of y.... , This was the experience of successive cohort...ondon,s) Department of Science and Technology Stud...vative approach to teaching is a full-blown academ...ociety for the History of Science (BSHS). , The b...
Other Biology News:Severely restricted diet linked to physical fitness into old age 2Natural product discovery by Cleveland medical researchers blocks tissue destruction 2
Rabbit Anti-TWIK-1 Antibody, Unconjugated from CHEMICON
Anti-Bunyavirus (G1) Monoclonal Antibody, Unconjugated, Clone 8C2.1 from CHEMICON
Rabbit Anti-BI-1 Polyclonal Antibody, Unconjugated from BioVision
Capped Xef-1 RNA 0.05 ml from Ambion
Biology Products: